Cargando…

Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting

The onset of cardiomyopathy is a common feature in sepsis, with relevant effects on its pathophysiology and clinical care. Septic cardiomyopathy is characterized by reduced left ventricular (LV) contractility eventually associated with LV dilatation with or without right ventricle failure. Unfortuna...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbone, Federico, Liberale, Luca, Preda, Alberto, Schindler, Thomas Hellmut, Montecucco, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496713/
https://www.ncbi.nlm.nih.gov/pubmed/36139408
http://dx.doi.org/10.3390/cells11182833
_version_ 1784794336546783232
author Carbone, Federico
Liberale, Luca
Preda, Alberto
Schindler, Thomas Hellmut
Montecucco, Fabrizio
author_facet Carbone, Federico
Liberale, Luca
Preda, Alberto
Schindler, Thomas Hellmut
Montecucco, Fabrizio
author_sort Carbone, Federico
collection PubMed
description The onset of cardiomyopathy is a common feature in sepsis, with relevant effects on its pathophysiology and clinical care. Septic cardiomyopathy is characterized by reduced left ventricular (LV) contractility eventually associated with LV dilatation with or without right ventricle failure. Unfortunately, such a wide range of ultrasonographic findings does not reflect a deep comprehension of sepsis-induced cardiomyopathy, but rather a lack of consensus about its definition. Several echocardiographic parameters intrinsically depend on loading conditions (both preload and afterload) so that it may be challenging to discriminate which is primitive and which is induced by hemodynamic perturbances. Here, we explore the state of the art in sepsis-related cardiomyopathy. We focus on the shortcomings in its definition and point out how cardiac performance dynamically changes in response to different hemodynamic clusters. A special attention is also given to update the knowledge about molecular mechanisms leading to myocardial dysfunction and that recall those of myocardial hibernation. Ultimately, the aim of this review is to highlight the unsolved issue in the field of sepsis-induced cardiomyopathy as their implementation would lead to improve risk stratification and clinical care.
format Online
Article
Text
id pubmed-9496713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94967132022-09-23 Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting Carbone, Federico Liberale, Luca Preda, Alberto Schindler, Thomas Hellmut Montecucco, Fabrizio Cells Review The onset of cardiomyopathy is a common feature in sepsis, with relevant effects on its pathophysiology and clinical care. Septic cardiomyopathy is characterized by reduced left ventricular (LV) contractility eventually associated with LV dilatation with or without right ventricle failure. Unfortunately, such a wide range of ultrasonographic findings does not reflect a deep comprehension of sepsis-induced cardiomyopathy, but rather a lack of consensus about its definition. Several echocardiographic parameters intrinsically depend on loading conditions (both preload and afterload) so that it may be challenging to discriminate which is primitive and which is induced by hemodynamic perturbances. Here, we explore the state of the art in sepsis-related cardiomyopathy. We focus on the shortcomings in its definition and point out how cardiac performance dynamically changes in response to different hemodynamic clusters. A special attention is also given to update the knowledge about molecular mechanisms leading to myocardial dysfunction and that recall those of myocardial hibernation. Ultimately, the aim of this review is to highlight the unsolved issue in the field of sepsis-induced cardiomyopathy as their implementation would lead to improve risk stratification and clinical care. MDPI 2022-09-11 /pmc/articles/PMC9496713/ /pubmed/36139408 http://dx.doi.org/10.3390/cells11182833 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Carbone, Federico
Liberale, Luca
Preda, Alberto
Schindler, Thomas Hellmut
Montecucco, Fabrizio
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title_full Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title_fullStr Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title_full_unstemmed Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title_short Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
title_sort septic cardiomyopathy: from pathophysiology to the clinical setting
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496713/
https://www.ncbi.nlm.nih.gov/pubmed/36139408
http://dx.doi.org/10.3390/cells11182833
work_keys_str_mv AT carbonefederico septiccardiomyopathyfrompathophysiologytotheclinicalsetting
AT liberaleluca septiccardiomyopathyfrompathophysiologytotheclinicalsetting
AT predaalberto septiccardiomyopathyfrompathophysiologytotheclinicalsetting
AT schindlerthomashellmut septiccardiomyopathyfrompathophysiologytotheclinicalsetting
AT montecuccofabrizio septiccardiomyopathyfrompathophysiologytotheclinicalsetting